Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 3520

BillFederalHouseIn Committee
Stem Cell Therapeutic and Research Reauthorization Act of 2019
About This Bill
Committee
Latest Action · June 27, 2019
Referred to the Subcommittee on Health.
Congress
116th (2019–2021)
Introduced
June 26, 2019
Cosponsors (3)
1D 2R
View PDF ↗

Summary

Highlight any text to annotate
Stem Cell Therapeutic and Research Reauthorization Act of 2019 This bill modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood. The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.